Jump to content

ACHA Webinar: The Latest Treatments for Congenitally Corrected Transposition of the Great Arteries (CCTGA)

Recommended Posts

The Latest Treatments for Congenitally Corrected Transposition of the Great Arteries (CCTGA) 

Date:  Wednesday, 6/23/2021

Time:  7 pm - 8 pm EDT

Presenter:  Salil Ginde, MD



About the Webinar

Did you know that the ventricles or pumping chambers in the hearts of people born with congenitally corrected transposition of the great arteries (CCTGA) are reversed? While the blood flow going to the body and lungs is normal, these individuals are still at risk for several challenges. One is the need for heart surgery early in life. Others include the development of symptoms caused by pump dysfunction, leaky heart valves, and abnormal electrical conduction of the heart. Dr. Salil Ginde will discuss these unique challenges. He will also talk about novel treatments designed to improve outcomes. If you want to learn more, register today for this webinar.

REGISTER NOW:  https://bit.ly/3gRgM3n

About the Presenter

Dr. Salil Ginde is a board certified adult congenital heart disease (ACHD) cardiologist and Associate Director of the ACHD Program at the Medical College of Wisconsin in Milwaukee, WI. He graduated from University of Illinois College of Medicine and then completed his residency in both Internal Medicine and Pediatrics at University of Chicago. He moved to Milwaukee in 2009 to complete his Pediatric Cardiology and ACHD Fellowship at Children’s Hospital of Wisconsin, where he currently practices.  

About the Adult Congenital Heart Association

The Adult Congenital Heart Association (ACHA) is a national not-for-profit organization dedicated to improving the quality of life and extending the lives of adults with congenital heart disease (CHD). ACHA serves and supports the nearly 2 million adults with CHD, their families, and the medical community—working with them to address the unmet needs of the long-term survivors of congenital heart defects through education, outreach, advocacy, and research. For more information about ACHA, contact (888) 921-ACHA or visit www.achaheart.org.


This webinar was made possible in part by an unrestricted educational grant from

Janssen, Inc. Pharmaceutical Companies of Johnson & Johnson.


Link to comment
Share on other sites

  • pala208 unpinned this topic

Join the conversation

You can post now and register later. If you have an account, sign in now to post with your account.

Reply to this topic...

×   Pasted as rich text.   Paste as plain text instead

  Only 75 emoji are allowed.

×   Your link has been automatically embedded.   Display as a link instead

×   Your previous content has been restored.   Clear editor

×   You cannot paste images directly. Upload or insert images from URL.


  • Create New...